Saltar al contenido
Merck

Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α.

Stem cell reports (2018-01-02)
Ivan Del Barco Barrantes, Camille Stephan-Otto Attolini, Konstantin Slobodnyuk, Ana Igea, Sara Gregorio, Sylwia Gawrzak, Roger R Gomis, Angel R Nebreda
RESUMEN

Mammary stem and progenitor cells are essential for mammary gland homeostasis and are also candidates for cells of origin of mammary tumors. Here, we have investigated the function of the protein kinase p38α in the mammary gland using mice that delete this protein in the luminal epithelial cells. We show that p38α regulates the fate of luminal progenitor cells through modulation of the transcription factor RUNX1, an important controller of the estrogen receptor-positive cell lineage. We also provide evidence that the regulation of RUNX1 by p38α probably involves the kinase MSK1, which phosphorylates histone H3 at the RUNX1 promoter. Moreover, using a mouse model for breast cancer initiated by luminal cells, we show that p38α downregulation in mammary epithelial cells reduces tumor burden, which correlates with decreased numbers of tumor-initiating cells. Collectively, our results define a key role for p38α in luminal progenitor cell fate that affects mammary tumor formation.

MATERIALES
Número de producto
Marca
Descripción del producto

Roche
Kit de detección de muerte celular in situ, fluoresceína, sufficient for ≤50 tests, suitable for detection
Sigma-Aldrich
Anticuerpo anti-actina, αmúsculo liso monoclonal de ratón, clone 1A4, purified from hybridoma cell culture